GlassScriptPhysician profile
Jacob M Andreasen
NPI 1023763695
$2,964.90
in general payments reported to CMS, 2019-2025
7 companies · $30.58 in 2025
The $30.58 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.39 · 2023: $2,795 · 2024: $43.17 · 2025: $30.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,833 · Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,833.44 |
| Food and Beverage | $1,035.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,440.76 | 2022-2024 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $1,280.17 | 2023 | Intracept |
| Abbvie INC. | $99.79 | 2022-2023 | |
| Vertos Medical, INC. | $66.95 | 2023 | Mild Device Kit |
| Regeneron Healthcare Solutions, INC. | $30.58 | 2025 | Eylea Hd |
| Genentech USA, INC. | $24.97 | 2024 | Vabysmo |
| Averitas Pharma INC. | $21.68 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Andreasen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.